Document Type
Report
Publication Date
1995
Abstract
This report presents the results of interviews conducted with 60 trained DMPA service providers from seven of the ten local government units (LGUs) covered by Phase I of the Philippine Department of Health's DMPA Reintroduction Program. DMPA, or Depot-medroxyprogesterone acetate, is an injectable contraceptive commonly known as Depo-Provera. The interviews were undertaken as part of the DMPA Monitoring and Follow-up Studies sponsored by the Population Council under the Asia and Near East Operations Research and Technical Assistance (ANE OR/TA) Project. While the monitoring study and the follow-up survey focused on DMPA users and dropouts, this study centered on the service provider. The DMPA Reintroduction Program was launched by the DOH in April 1994 by the Philippine Bureau of Food and Drugs. The program aims to reintroduce DMPA into the Philippine Family Planning Program through training local-level doctors, nurses, and midwives as service providers, and providing free DMPA services in selected public health facilities.
Recommended Citation
Patron, Maria Carmela and Marilou Palabrica-Costello. 1995. "The DMPA service provider: Profile, problems and prospects, August 1995," Asia & Near East Operations Research and Technical Assistance Project Special Report. Manila: Population Council, Department of Health, and Family Planning Operations Research and Training Program.
DOI
10.31899/rh1995.1024
Language
English
Project
Asia & Near East Operations Research and Technical Assistance Project
Included in
Demography, Population, and Ecology Commons, Health Services Research Commons, International Public Health Commons